跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,059 条关于
“MTC”
全部
3,059
临床试验
2,295
药物
514
机构
41
资讯
209
去年
FDA Approves Lilly's Retevmo as First Targeted Therapy for RET-Positive Lung and Thyroid Cancers
去年
SY-5007 Demonstrates Promising Efficacy in RET-Altered Solid Tumors: Phase 1 Trial Results
去年
Nivolumab and Ipilimumab Show Promise in Aggressive Thyroid Carcinoma Subtypes
去年
FDA Grants Full Approval to Selpercatinib for RET-Mutant Medullary Thyroid Cancer
去年
CStone Pharmaceuticals Receives NMPA Approval for Local Manufacturing of RET Inhibitor GAVRETO in China
12个月前
Kelun-Biotech's Next-Generation RET Inhibitor A400/EP0031 Receives NDA Acceptance in China for NSCLC Treatment
去年
TauRx Secures $119 Million Investment as Novel Tau-Targeting Alzheimer's Drug Advances Toward Regulatory Filing
去年
Teva Launches First Generic GLP-1 Weight Loss Drug as FDA Approves Generic Saxenda
去年
Precision Medicine Approach Shows Promise in Anaplastic Thyroid Cancer
3个月前
Kelun-Biotech's Lunbotinib Fumarate Shows Promising Phase II Results in RET Fusion-Positive NSCLC
第 1 页,共 21 页
上一页
下一页